Despite its proven effectiveness as a treatment for opioid use disorders (OUD), buprenorphine is not reaching patients in central Appalachia, the epicenter of the opioid crisis in the United States, according to investigators from the Emory Rollins School of Public Health.
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.
Please enter your username or email address. You will receive a link to create a new password via email.
Get New Password
Please enter your email. You'll receive an email with your one-time use Snappy Login Link™. Just click the link within 15 minutes to automatically login.
Get Snappy Login Link™